EnteroBiotix announces partnership with Imperial College London
Collaboration includes a phase 2 clinical trial using microbiome therapeutics funded by the MRC
Read More
Tag: Imperial College
PIONEER COVID-19 trial wins funding injection from LifeArc
The funds will enable researchers to investigate the science around the trial, including why coronavirus affects some people more than others
Read More
Groundbreaking study finds optimum dosage of IV iron for kidney patients
New iron-trial results have paved the way for improved haemodialysis treatment.
Read More
Lewy Body Society grants £1 million for dementia research
The Lewy Body Society has announced that the latest recipients of its grant programme will be University of Cambridge, Newcastle University and Imperial College London.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
